ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,906Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 5176

$958K Total Retail Price of All Prescriptions

Rank: 290 out of 5176

531 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 531 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

2% of this provider’s 531 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

0% of this provider’s 17,471 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 915 868 1 8
METOPROLOL TARTRATE 811 755 2 6
LEVOTHYROXINE SODIUM 749 722 3 4
SIMVASTATIN 665 600 4 1
OMEPRAZOLE 595 586 5 3
AMLODIPINE BESYLATE 591 559 6 2
DONEPEZIL HCL 581 566 7 28
POTASSIUM CHLORIDE 563 533 8 34
WARFARIN SODIUM 462 462 9 13
LISINOPRIL 421 414 10 5
MIRTAZAPINE 399 392 11 45
SERTRALINE HCL 362 325 12 30
RISPERIDONE 325 317 13 78
CITALOPRAM HBR 304 293 14 31
DIGOXIN 287 287 15 56
METOPROLOL SUCCINATE 233 232 16 11
NAMENDA 230 230 17 47
GABAPENTIN 212 159 18 21
LOSARTAN POTASSIUM 209 190 19 14
RANITIDINE HCL 200 193 20 36
METFORMIN HCL 199 164 21 7
QUETIAPINE FUMARATE 197 188 22 75
ENALAPRIL MALEATE 197 177 22 22
DIVALPROEX SODIUM 169 130 24 104
LANTUS 160 133 25 66
CLOPIDOGREL 159 137 26 26
ISOSORBIDE MONONITRATE ER 156 156 27 44
SPIRONOLACTONE 155 154 28 88
FAMOTIDINE 153 134 29 58
TAMSULOSIN HCL 152 126 30 20
ZOLPIDEM TARTRATE 151 137 31 17
CARVEDILOL 150 148 32 24
CYMBALTA 141 117 33 90
ADVAIR DISKUS 138 124 34 32
ATENOLOL 138 119 34 12
JANUVIA 130 94 36 25
PLAVIX 114 101 37 29
OXYCODONE-ACETAMINOPHEN 103 89 S2 38 101
ATORVASTATIN CALCIUM 100 100 39 9
FINASTERIDE 97 77 40 69
AMIODARONE HCL 96 95 41 281
ALLOPURINOL 96 85 41 41
DILTIAZEM 24HR CD 89 89 43 119
LACTULOSE 89 85 43 87
PREDNISONE 85 85 45 52
FENTANYL 84 72 S2 46 172
DIOVAN 84 84 46 19
ESCITALOPRAM OXALATE 82 63 48 89
LOVASTATIN 81 77 49 46
BUSPIRONE HCL 81 44 49 183
ALENDRONATE SODIUM 80 80 51 18
CARBIDOPA-LEVODOPA 79 68 52 98
NYSTATIN-TRIAMCINOLONE 78 76 53 142
LEVETIRACETAM 78 51 53 92
POLYETHYLENE GLYCOL 3350 76 71 55 74
FLUTICASONE PROPIONATE 75 65 56 38
SINGULAIR 75 67 56 62
PANTOPRAZOLE SODIUM 72 72 58 61
SANTYL 71 68 59 124
CIPROFLOXACIN HCL 70 65 60 84
FLUOXETINE HCL 69 56 61 132
SPIRIVA 68 68 62 54
TRAZODONE HCL 65 62 63 71
AZITHROMYCIN 64 64 64 42
HYDROCHLOROTHIAZIDE 63 54 65 10
NITROGLYCERIN PATCH 62 61 66 149
LIDODERM 62 61 66 59
BUPROPION HCL 61 61 68 444
SEROQUEL 59 58 69 166
METHIMAZOLE 57 57 70 331
MUPIROCIN 55 55 71 182
LATANOPROST 54 54 72 185
NOVOLOG 54 49 72 168
MONTELUKAST SODIUM 53 48 74 123
CLONIDINE HCL 51 51 75 79
CELEBREX 51 47 75 80
ACTONEL 50 37 77 134
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.